Skip to main content
3SBio Inc. logo

3SBio Inc. — Investor Relations & Filings

Ticker · 1530 ISIN · KYG8875G1029 LEI · 529900P0TQC1E9Y7FN31 HKEX Manufacturing
Filings indexed 1,490 across all filing types
Latest filing 2024-07-19 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1530

About 3SBio Inc.

http://www.3sbio.com

3SBio Inc. is a biopharmaceutical enterprise specializing in the integrated research, development, production, and commercialization of innovative biopharmaceutical products. The company operates as a biotechnology firm, focusing on the discovery, development, manufacture, and marketing of biologics, with a particular emphasis on mammalian cell-based biopharmaceuticals. 3SBio addresses critical medical needs by providing an extensive range of products and services to markets both domestically and internationally.

Recent filings

Filing Released Lang Actions
(Revised) Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares, treasury shares, share buybacks, and on-market sales of treasury shares for 3SBio Inc. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) related to disclosure of share repurchases and changes in issued shares. The content includes detailed tables of share repurchase transactions, dates, prices, and confirmations of compliance with listing rules. There is no financial performance data, earnings information, or management discussion. The document is a regulatory disclosure about share repurchases and treasury share transactions, which fits the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2024-07-19 English
INSIDE INFORMATION ANNOUNCEMENT
Capital/Financing Update Classification · 90% confidence The document is an announcement made pursuant to rule 13.09 of the Listing Rules of The Stock Exchange of Hong Kong Limited, indicating it is an inside information announcement. It provides a preliminary assessment of the company's expected financial performance for the six months ended 30 June 2024, specifically a significant estimated loss related to joint ventures. The announcement explicitly states that the information is preliminary, unaudited, and that the company will announce the unaudited consolidated interim results later in August 2024. The document is relatively short (3532 characters) and serves as a cautionary announcement to shareholders and investors about expected financial results, not the actual interim report itself. Therefore, it is an update on financial performance prior to the formal interim report release, fitting the category of Capital/Financing Update (CAP) or possibly Regulatory Filings (RNS). However, since it is an inside information announcement about expected financial results and not a full interim report or earnings release, and it is not a simple regulatory compliance filing, the best fit is Capital/Financing Update (CAP).
2024-07-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly report on movements in securities for 3SBio Inc., including authorized share capital, issued shares, treasury shares, share options, and repurchase activities. It is addressed to the Hong Kong Exchanges and Clearing Limited and relates to the month ended 30 June 2024. The content focuses on share capital changes, share repurchases, and treasury shares movements, which are typical of announcements regarding share capital changes or share repurchase activities. There is no indication of financial statements, earnings data, management discussion, or audit information. The document is not a report publication announcement or a certification but a substantive report on share capital movements. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA).
2024-07-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024
Regulatory Filings Classification · 95% confidence The document is a monthly return report for an equity issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules. It details movements in authorised/registered share capital, issued shares, treasury shares, and confirms no changes in share options, warrants, convertibles, or other arrangements. The document is submitted to the Hong Kong Exchanges and Clearing Limited and is a regulatory compliance filing related to share capital movements. It is not an annual or interim financial report, earnings release, or management discussion. It is also not a proxy, voting result, or remuneration report. The document fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about share capital and securities movements without substantive financial statements or detailed financial analysis.
2024-07-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and sales. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed transactional data such as number of shares repurchased, prices, dates, and confirmations of compliance with listing rules. The content is focused on share capital changes and repurchase activities, with no financial statements or earnings data. It is a regulatory disclosure related to share transactions rather than a financial report or earnings release. Therefore, the document fits best under the category of Transaction in Own Shares (POS). The document length and detail confirm it is a full disclosure report, not just an announcement or certification, supporting a high confidence level.
2024-06-28 English
Next Day Disclosure Return
Regulatory Filings Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share capital changes and repurchase activities, not a full financial report or earnings release. It is a formal regulatory filing required by the exchange to disclose share transactions and treasury share movements. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a compliance document reporting share capital changes and repurchases, not a report or announcement of a report.
2024-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.